Supplier News

Marco Chiadò Piat, President, Pharmaceutical Solutions Division, Terumo Medical Solutions, outlined a $500-million expansion plan, which includes an acquisition and organic growth, at the DCAT Member Company Announcement Forum, held…

James Chen, CEO, Agno Pharmaceuticals, outlined the company’s expansion activity in small-molecule active pharmaceutical ingredients (APIs) and GMP intermediates and drug-product development and manufacturing, at the DCAT Member Company Announcement…

Aileen Ruff-Patry, President, Contract Manufacturing, West Pharmaceutical Services, outlined recent expansions by the company to support development and commercialization of medical devices, drug-delivery systems, and combination products through manufacturing, device…

In late 2025, Wilmington PharmaTech, a US-based active parmaceutical ingredient (API), announced a partnership with Curewell Capital, a healthcare-focused private equity firm, to support the company’s continued expansion. Kent Payne,…

Denis Johnson, CEO, Grand River Aseptic Manufacturing (GRAM), a CDMO of injectables, is expanding its capabilities in response to increasing demand for sterile manufacturing in the US. As part of…

Martin Meeson, CEO of Axplora, a CDMO of active pharmaceutical ingredient (API) manufacturing, highlighted the company’s $60-million investment program at the company’s Farmabios site in Gropello Cairoli, Italy, at the…

Peng Jiao, PhD, CEO, of the Boston Institute of Biotechnology (BIB), outlined the company’s biomanufacturing expansions at the DCAT Member Company Announcement Forum, held March 23, 2026, at DCAT Week.…

BSP Pharmaceuticals is advancing a major expansion of its manufacturing capacity, as part of a revised mid- to long-term strategic plan, designed to support growing global demand for complex biologics…

Waldo Mossi, CEO, HAS Healthcare Advanced Synthesis Group, outlined the company’s expansion plan and integration of its acquisition of the CDMO Cerbios-Pharma at the DCAT Member Company Announcement Forum, held…